Cronus Pharma draws PE interest four years after failed Aurobindo deal
Advertisement

Cronus Pharma draws PE interest four years after failed Aurobindo deal

By Debjyoti Roy

  • 13 Aug 2025
Pro
Cronus Pharma draws PE interest four years after failed Aurobindo deal
Credit: Pexels

Cronus Pharma, an animal healthcare company that top Indian drugmaker Aurobindo Pharma wanted to acquire in 2021 before cancelling the deal, has now attracted interest from a few private equity investors, two people familiar with the development told VCCircle. The company, which manufactures general and cephalosporin veterinary finished dosage formulations, including ......

New to VCCircle.com?

Subscribe to VCCircle PRO and get privileged access to exclusive curated articles!

Already a VCCircle PRO member? Click here to log in.
Advertisement
Advertisement
Google News Icon

Google News

Follow VCCircle on Google News for the latest updates on Business and Startup News